No IPOs are currently scheduled in the week ahead, although smaller issuers may join the calendar throughout the week. Read ...
Street research is expected for four companies in the week ahead, and six lock-up periods will be expiring.
Hair loss–focused Veradermics and cancer biotech Eikon follow the lead of Aktis Oncology, which last week announced a $318 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback